These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 36001450)

  • 1. Development and validation of novel RP-HPLC method for midostaurin determination using analytical quality by design approach from regulatory perspective and determination of major degradation compounds of midostaurin using LC-MS.
    Reddy Saddala MP; Konduru N; Gundla R; Kowtharapu LP
    Biomed Chromatogr; 2022 Dec; 36(12):e5486. PubMed ID: 36001450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Favipiravir (SARS-CoV-2) degradation impurities: Identification and route of degradation mechanism in the finished solid dosage form using LC/LC-MS method.
    Vemuri DK; Gundla R; Konduru N; Mallavarapu R; Katari NK
    Biomed Chromatogr; 2022 Jun; 36(6):e5363. PubMed ID: 35292997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A validated stability-indicating reversed-phase-HPLC method for dipyridamole in the presence of degradation products and its process-related impurities in pharmaceutical dosage forms.
    Mallavarapu R; Katari NK; Dongala T; Rekulapally VK; Marisetti VM; Vyas G
    Biomed Chromatogr; 2022 Jan; 36(1):e5247. PubMed ID: 34541698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability-indicating HPLC method development and validation of rivaroxaban impurities and identification of forced degradation products using LC-MS/MS.
    Cholleti V; Ravindra Kumar Y; Pasula A; Surya PRP
    Biomed Chromatogr; 2022 Sep; 36(9):e5424. PubMed ID: 35697473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a novel stability-indicating HPLC method for the quantitative determination of eleven related substances in ezetimibe drug substance and drug product.
    Luo Z; Deng Z; Liu Y; Wang G; Yang W; Hou C; Tang M; Yang R; Zhou H
    Talanta; 2015 Jul; 139():67-74. PubMed ID: 25882410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Degradation pathways and impurity profiling of the anticancer drug apalutamide by HPLC and LC-MS/MS and separation of impurities using Design of Experiments.
    Lakka NS; Kuppan C; Vadagam N; Reddamoni SY; Muthusamy C
    Biomed Chromatogr; 2023 Feb; 37(2):e5549. PubMed ID: 36409057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impurity profiling and stability-indicating method development and validation for the estimation of assay and degradation impurities of midostaurin in softgel capsules using HPLC and LC-MS.
    Lakka NS; Kuppan C; Ravinathan P
    Biomed Chromatogr; 2021 Dec; 35(12):e5222. PubMed ID: 34331472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unique Quality by Design Approach for Developing HPLC and LC-MS Method for Estimation of Process and Degradation Impurities in Pibrentasvir, Antiviral Agent for Hepatitis C.
    Vemuri DK; Akshinthala P; Konduru N; Kowtharapu LP; Katari NK; Jonnalagadda SB; Gundla R
    ACS Omega; 2022 Dec; 7(51):47650-47661. PubMed ID: 36591161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impurity assessment, development and validation of an RP-HPLC method for the determination of eleven potential impurities of eltrombopag precursor.
    Demirhan T; Guksu E; Yazar Y; Keskin E; Bellur Atici E; Özkan SA
    J Pharm Biomed Anal; 2024 Jun; 243():116085. PubMed ID: 38471254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UPLC and LC-MS studies on degradation behavior of irinotecan hydrochloride and development of a validated stability-indicating ultra-performance liquid chromatographic method for determination of irinotecan hydrochloride and its impurities in pharmaceutical dosage forms.
    Kumar N; Sangeetha D; Reddy SP
    J Chromatogr Sci; 2012 Oct; 50(9):810-9. PubMed ID: 22661461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LC and LC-MS/MS study of forced decomposition behavior of anastrozole and establishment of validated stability-indicating analytical method for impurities estimation in low dose anastrozole tablets.
    Reddy YR; Nandan SR; Bharathi DV; Nagaraju B; Reddy SS; Ravindranath LK; Rao VS
    J Pharm Biomed Anal; 2009 Oct; 50(3):397-404. PubMed ID: 19541446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LC-MS-Compatible Chromatographic Method for Quantification of Potential Organic Impurities of Elagolix Sodium in Tablet Dosage Form with Identification of Major Degradation Products.
    Desai P; Prajapati R; Chokshi A
    J AOAC Int; 2023 May; 106(3):568-579. PubMed ID: 36721330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a stability-indicating, single HPLC method for sacubitril-valsartan and their stereoisomers and identification of forced degradation products using LC-MS/MS.
    Vijaykumar C; Kumar YR; Aparna P; Rao PSP
    Biomed Chromatogr; 2023 Feb; 37(2):e5550. PubMed ID: 36410774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A validated stability-indicating RP-HPLC method for levofloxacin in the presence of degradation products, its process related impurities and identification of oxidative degradant.
    Lalitha Devi M; Chandrasekhar KB
    J Pharm Biomed Anal; 2009 Dec; 50(5):710-7. PubMed ID: 19632800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability-indicating method development and validation for quantitative estimation of assay and organic impurities of antiviral drug baloxavir marboxil in drug substance and pharmaceutical dosage form using HPLC and LC-MS methods.
    Nagulancha BR; Lakka NS; Vandavasi KR
    Biomed Chromatogr; 2023 Aug; 37(8):e5644. PubMed ID: 37052118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability-indicating LC method for the estimation of bendamustine hydrochloride and its related impurities.
    Kasa S; Raja Sekhar Reddy M; Kadaboina RS; Murki V; Mulukutla VS
    J Chromatogr Sci; 2014 Aug; 52(7):573-83. PubMed ID: 23825351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simple isocratic LC method for quantification of trace-level inorganic degradation impurities (ferricyanide, ferrocyanide, nitrite, and nitrate) in sodium nitroprusside injection and robustness by quality using design approach.
    Yenda P; Katari NK; Dongala T; Vyas G; Katakam LNR; Ettaboina SK
    Biomed Chromatogr; 2022 Feb; 36(2):e5269. PubMed ID: 34693546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of stability-indicating UHPLC method for the quantitative determination of silodosin and its related substances.
    Shaik JV; Saladi S; Sait SS
    J Chromatogr Sci; 2014 Aug; 52(7):646-53. PubMed ID: 23845884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Stability Indicating Method Development and Validation for Separation of Process Related Impurities and Characterization of Unknown Impurities of Tyrosine Kinase Inhibitor Ibrutinib Using QbD Approach by RP-HPLC, NMR Spectroscopy and ESI-MS.
    Gopireddy RR; Maruthapillai A; Mahapatra S
    J Chromatogr Sci; 2021 Sep; 59(9):830-846. PubMed ID: 33420506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A quality-by-design evaluated liquid chromatography method development and validation for the separation and quantification of nitroxoline and its impurities.
    Lankalapalli SP; Rachel KV; Chintala V; Kowtharapu LP; Katari NK
    J Sep Sci; 2024 Jan; 47(1):e2300760. PubMed ID: 38135885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.